# Aspirin for Prophylaxis of TTP

> **NCT05568147** · PHASE2,PHASE3 · NOT_YET_RECRUITING · sponsor: **The First Affiliated Hospital of Soochow University** · enrollment: 100 (estimated)

## Conditions studied

- Thrombotic Thrombocytopenic Purpura

## Interventions

- **DRUG:** Aspirin tablet
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05568147
- **Lead sponsor:** The First Affiliated Hospital of Soochow University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2022-10-01
- **Primary completion:** 2027-09-30
- **Final completion:** 2028-09-30
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-10-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05568147

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05568147, "Aspirin for Prophylaxis of TTP". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05568147. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*